Common use of Terms Defined Elsewhere Clause in Contracts

Terms Defined Elsewhere. As used in this Agreement, the following capitalized terms are defined in this Agreement as referenced in the following table: Agreement Preamble Anti-Corruption Laws 5.5(d) Bylaws 3.2 Change of Recommendation 7.2(d)(i)(G) Charter 3.1 Closing 2.1 Closing Date 2.1 Company Preamble Company Approvals 5.4(a) Company Disclosure Letter Article V Company Personal Information 5.18(l) Company Recommendation 5.3(b) D&O Insurance 7.12(a) Delisting Period 7.18(a) Effective Time 2.2 Exchange Fund 4.3(a)(i) Excluded Share 4.1(b) Governmental Antitrust Entity 7.6(b)(ii) Interim Period 7.1(a) Lease 5.17(a) Legal Restraint 8.1(c) Material Contract 5.11(a)(xvi) Material Payor 5.12(a) Material Vendor 5.12(b) Merger Recitals Merger Consideration 4.1(a) Merger Sub Preamble Non-Wholly Owned Subsidiary 5.2(f) Notice 7.2(d)(iii) Notice Period 7.2(d)(iii) Original Date 7.4(b) Outside Date 9.2(a) Parent Preamble Parent Approvals 6.4(a) Parent Option 4.2(a)(ii) Parent RSA 4.2(b) Parties Preamble Permitted Confidentiality Agreement 7.2(b)(i) Potential Purchasers 7.6(d) Potential Sale Transaction 7.6(d) Privacy and Security Requirements 5.18(k) Proxy Statement 7.3(a) Subsidiary Partnership 5.16(o) Surviving Corporation 2.3 Third-Party Consents 7.8 Transaction Litigation 7.15

Terms Defined Elsewhere. As used in this Agreement, the following capitalized terms are defined in this Agreement as referenced in the following table: Agreement Preamble Anti-Corruption Laws 5.5(d) Bylaws 3.2 Capitalization Date Change of Recommendation 7.2(d)(i)(GCharter 3.2 5.2(a) Charter 7.2(d) (i)(F) 3.1 Closing 2.1 Closing Date 2.1 Company Preamble Company Approvals 5.4(a) Company Disclosure Letter Article V Company Personal Information 5.18(l) Company Recommendation 5.3(b) Company Tax Representation Letter Continuation Period D&O Insurance 7.12(a) Delisting Period 7.18(a) Effective Time 2.2 Exchange Fund 4.3(a)(i) Excluded Share 4.1(b) FDA FDA Licenses Fundamental Action Governmental Antitrust Entity 7.6(b)(ii) Interim Period 7.1(a) Lease 5.17(a) Legal Restraint 8.1(c) Material Contract 5.11(a)(xvi) Material Payor 5.12(a) Customer Material Vendor 5.12(b) Merger Recitals Merger Consideration 4.1(a) Merger Sub Preamble Non-Wholly Owned Subsidiary 5.2(f) Notice 7.2(d)(iii) of Redemption Notice Notice Period 7.2(d)(iii) Original Date 7.4(b) Outside Date 9.2(a) Parent Preamble Parent Approvals 6.4(a) Parent DSU Parent Option 4.2(a)(ii) Parent RSA 4.2(b) RSU Parent Tax Representation Letter Parent SAR Parties Preamble Permitted Confidentiality Agreement 7.2(b)(i) Potential Purchasers 7.6(d) Potential Sale Transaction 7.6(d) Privacy and Security Requirements Measures Privacy-Related Contracts Proxy Statement 2.1 Preamble 5.4(a) Article V 5.18(l) 5.3(b) 7.18(c) 7.11(a) 7.12(b) 7.17(a) 2.2 4.3(a)(i) 5.20(a) 5.20(a) 7.2(d)(iii) 7.6(b)(ii) 7.1(a) 8.1(c) 5.11(a) 5.12(a) 5.12(b) Recitals Preamble 5.2(f) 7.13(a) 7.2(d)(iii) 7.2(d)(iii) 9.2(a) Preamble 6.4(a) 4.2(f) 4.2(a) 4.2(c) 7.18(c) 4.2(e) Preamble 7.2(b)(i) 7.6(d) 7.6(d) 5.18(k) Proxy Statement 5.11(a)(vi) 7.3(a) Subsidiary Partnership 5.16(o) -2- Stock Ownership Rep Support Agreement Surviving Corporation 2.3 Tax Representation Letters Third-Party Consents 7.8 Transaction Litigation 7.156.8 Recitals 2.3 7.18(c) 7.8

Terms Defined Elsewhere. As The following is a list of additional terms used in this Agreement, Agreement and a reference to the following capitalized terms are defined Section hereof in this Agreement as referenced in the following tablewhich such term is defined: Acquisition Sub Preamble Acquisition Sub Company Common Stock 2.8(c) Agreement Preamble Anti-Corruption Antitrust Laws 5.5(d5.5 Certificates 2.10(b) Bylaws 3.2 Change of Recommendation 7.2(d)(i)(GClosing 2.3(a) Charter 3.1 Closing 2.1 Adjustment 2.14(b) Closing Cash 2.14(a) Closing Cash Target 2.14(a) Closing Consideration Allocation Schedule 2.9(c) Closing Date 2.1 2.3(a) COBRA Coverage 3.12(e) Collective Bargaining Agreement 3.17(a) Company Preamble Company Approvals 5.4(aAssets 3.5 Company Bylaws 2.3(c)(ii) Company Disclosure Letter Schedule Article V Company Personal Information 5.18(lIII: Preamble Company-Owned Intellectual Property 3.18(a) Company Recommendation 5.3(bStockholder Approval 3.3(b) D&O Insurance 7.12(aCompany Warrants 3.4(c) Delisting Period 7.18(aConfidentiality Agreement 5.4(d) Copyrights 3.18(a) DGCL 4.3(a) Dissenting Shares 2.12 DOJ 5.5(b) Early Termination Election 7.1(c) Early Termination Override Notice 7.1(c) Effective Time 2.2 Employee Plans 3.12(a) Employment Agreements 2.3(b)(iv) Estimated Closing Cash 2.14(b) Exchange Fund 4.3(a)(iAct 4.5(a) Excluded Share 4.1(bFCPA 3.25(a) Governmental Antitrust Entity 7.6(b)(iiFTC 5.5(b) Interim Period 7.1(aGeneral Enforceability Exceptions 3.3(a) Lease 5.17(aIn-Bound License Agreements 3.6(a)(v) Legal Restraint 8.1(cIndemnified Officers 5.7(a) Infringes 3.18(d) Insurance 3.19 Intellectual Property 3.18(a) Letter of Transmittal 2.10(b) License Agreement 3.6(a)(v) Material Contract 5.11(a)(xvi) Material Payor 5.12(a) Material Vendor 5.12(bContracts 3.6(a) Merger Recitals 2.1 Merger Consideration 4.1(aCertificate 2.2 Money Laundering Laws 3.25(b) Merger Sub Preamble Multi-Employer Plan 3.12(a) Non-Wholly Owned Subsidiary 5.2(fUnion Employees 5.8(a) Notice 7.2(d)(iii) Notice Period 7.2(d)(iii) Original Date 7.4(bNRS 2.1 Out-Bound License Agreements 3.6(a)(v) Outside Date 9.2(a7.1(b) Parent Preamble Parent Approvals 6.4(aSEC Documents 4.5(a) Parent Option 4.2(a)(iiStockholder Approval 4.3(b) Parent RSA 4.2(bParty Representative 5.2(a) Parties Patents 3.18(a) Payoff Letter 2.9(b) Pre-Closing Taxes 3.10(a) Real Property Leases 3.7(a) Real Property Permits 3.7(g) Record Retention Period 5.12 Representative Preamble Permitted Confidentiality Agreement 7.2(b)(iRequested Information 5.4(b) Potential Purchasers 7.6(d▇▇▇▇▇▇▇▇-▇▇▇▇▇ Act 4.5(a) Potential Sale Transaction 7.6(dSEC 4.5(a) Privacy and Security Requirements 5.18(kSecurities Act 4.5(a) Proxy Statement 7.3(aSettlement Accountants 2.13(e) Subsidiary Partnership 5.16(oSoftware 3.18(a) Special Meeting 5.3(e) Stock Plan 3.4(b) Surviving Corporation 2.3 Third-2.1 Systems 3.18(o) Third Party Consents 7.8 Intellectual Property 3.18(b) Trade Secrets 3.18(a) Trademarks 3.18(a) Transaction Litigation 7.15Fee Statement 2.9(a) WARN Act Laws 3.17(d)

Terms Defined Elsewhere. As used in this Agreement, the The following capitalized terms are defined in this Agreement as referenced in the following tablesections of this Agreement: Acquisition Proposal 4.2(b) Affiliate 9.2 Agreement Preamble Anti-Corruption Laws 5.5(dAggrieved Party 7.2(a) Bylaws 3.2 ALLL 3.16(a) Balance Sheet Date 3.8(a) Bank Merger Preamble Bank Merger Effective Time 1.4(a) Bank Regulations 1.1 Bank Regulators 9.2 Breaching Party 7.2(a) Certificates 1.3(c)(i) CGLC 1.1(a) Change of Recommendation 7.2(d)(i)(GControl Benefit 3.17(e) Charter 3.1 Closing 2.1 1.5 Closing Date 2.1 1.5 Closing Financial Statements 4.8 Code 3.13(b) Company Preamble Company Approvals 5.4(aBank Preamble Company Bank Common Stock 1.4(a) Company Disclosure Letter Article V Company Personal Information 5.18(lCommon Stock 1.3(b) Company Recommendation 5.3(bEntities Premises 3.18(b) D&O Insurance 7.12(aCompany Real Property 3.20(c) Delisting Period 7.18(aCompany SEC Reports 3.9(b) Company Shareholders’ Meeting 4.3 Company Stock Option Plan 3.6(b) Company Stock Options 3.6(b) Company Bank Regulatory Agreement 3.22(b) CRA 2.7(c) Derivative Instruments 3.19(e)(iv) Determination Date 4.8 Dissenting Shares 1.3(b) Effective Time 2.2 1.2 Encumbrance 9.2 Environmental Laws 9.2 Exchange Fund 4.3(a)(iAgent 1.3(c)(i) Excluded Share 4.1(bExchange Act 3.4(a) (a) Governmental Antitrust Entity 7.6(b)(ii2.4(a) (a) Interim Period 7.1(a) Lease 5.17(a) Legal Restraint 8.1(cKnowledge 9.2 Law 3.4(b) Material Adverse Effect 9.2 Material Contract 5.11(a)(xvi) Material Payor 5.12(a) Material Vendor 5.12(b3.19(a) Merger Recitals Preamble Merger Agreement 1.2 Merger Consideration 4.1(a1.3(a)(i) Merger Sub Preamble Non-Wholly Owned Subsidiary 5.2(f) Notice 7.2(d)(iii) Notice Period 7.2(d)(iii) Original Date 7.4(b) Outside Date 9.2(aConsideration Adjustment 1.3(c)(ii) Parent Preamble Parent’s Agents 5.11 Parent SEC Reports 2.6(a) Permitted Encumbrances 3.20(a) Per Share Merger Consideration 1.3(c)(ii) Person 9.2 Preferred Share Purchase Rights 3.6(b) Required Regulatory Approvals 6.4(a3.25 Rights Plan 3.6(b) Parent Option 4.2(a)(ii) Parent RSA 4.2(b) Parties Preamble Permitted Confidentiality Securities Act 3.5 Shareholder Agreement 7.2(b)(i) Potential Purchasers 7.6(d) Potential Sale Transaction 7.6(d) Privacy and Security Requirements 5.18(k) Proxy Statement 7.3(a6.2(e) Subsidiary Partnership 5.16(o) Surviving Corporation 2.3 Third-Party Consents 7.8 Transaction Litigation 7.159.2

Terms Defined Elsewhere. As Each of the following capitalized terms, when used in this Agreement, has the following capitalized terms are defined meaning provided for such term in the Section of this Agreement as referenced in the following tableset forth beside such term below: Agreement Preamble Anti-Corruption Laws 5.5(dTerm Section Additional Interests 3.05(b) Bylaws 3.2 Change of Recommendation 7.2(d)(i)(GAdjusted Capital Account Exhibit C Aggregate Consideration 8.03(b) Charter 3.1 Authorized Person 2.01 Board 5.01(a) Capital Account 3.03 Closing 2.1 Closing Date 2.1 10.03 Company Preamble Introductory Paragraph Company Approvals 5.4(aMinimum Gain Exhibit C Company Tax Rep 4.04(c) Company Disclosure Letter Article V Company Personal Information 5.18(lDissolution Event 9.01(a) Company Recommendation 5.3(bDistribution Threshold 2.09(c) D&O Insurance 7.12(aExisting Owners 3.05(c) Delisting Period 7.18(aFirm 11.14 IPO 3.05(b) Effective Time 2.2 Exchange Fund 4.3(a)(iLater Year 4.04(c) Excluded Share 4.1(bMajority Member Introductory Paragraph Member Nonrecourse Debt Exhibit C Member Nonrecourse Debt Minimum Gain Exhibit C Member Nonrecourse Deductions Exhibit C Minority Member Representative 5.02(a) Governmental Antitrust Entity 7.6(b)(iiNonrecourse Deductions Exhibit C Nonrecourse Liability Exhibit C Partnership Representative 4.04(c) Interim Period 7.1(aPublic Safety 8.01 Put Notice 10.01 Representative 5.01(a) Lease 5.17(aRedemption Price 10.02 Safe Harbor Election 4.08 Tax Distributions 4.02(b) Legal Restraint 8.1(cTax Matters Member 4.04(c) Material Contract 5.11(a)(xviTransfer 8.01 Transfer Notice 8.02(a) Material Payor 5.12(aTransferor 8.02(a) Material Vendor 5.12(bUltimate Rules 4.08 Unitholder 4.04(c) Merger Recitals Merger Consideration 4.1(a) Merger Sub Preamble Non-Wholly Owned Subsidiary 5.2(f) Notice 7.2(d)(iii) Notice Period 7.2(d)(iii) Original Date 7.4(b) Outside Date 9.2(a) Parent Preamble Parent Approvals 6.4(a) Parent Option 4.2(a)(ii) Parent RSA 4.2(b) Parties Preamble Permitted Confidentiality Agreement 7.2(b)(i) Potential Purchasers 7.6(d) Potential Units Sale Transaction 7.6(d) Privacy and Security Requirements 5.18(k) Proxy Statement 7.3(a) Subsidiary Partnership 5.16(o) Surviving Corporation 2.3 Third-Party Consents 7.8 Transaction Litigation 7.158.03(a)

Terms Defined Elsewhere. As used in this Agreement, the following capitalized terms are defined in this Agreement as referenced in the following table: Agreement Preamble Anti-Corruption Laws 5.5(d) Bylaws 3.2 Capitalization Date 5.2(a) Change of Recommendation 7.2(d)(i)(G7.2(d)(i)(F) Charter 3.1 Closing 2.1 Closing Date 2.1 Company Preamble Company Approvals 5.4(a) Company Disclosure Letter Article V Company Personal Information 5.18(l) Company Recommendation 5.3(b) Company Tax Representation Letter 7.18(c) Continuation Period 7.11(a) D&O Insurance 7.12(a7.12(b) Delisting Period 7.18(a7.17(a) Effective Time 2.2 Exchange Fund 4.3(a)(i) Excluded Share 4.1(bFDA 5.20(a) FDA Licenses 5.20(a) Fundamental Action 7.2(d)(iii) Governmental Antitrust Entity 7.6(b)(ii) Interim Period 7.1(a) Lease 5.17(a) Legal Restraint 8.1(c) Material Contract 5.11(a)(xvi5.11(a) Material Payor Customer 5.12(a) Material Vendor 5.12(b) Merger Recitals Merger Consideration 4.1(a) Merger Sub Preamble Non-Wholly Owned Subsidiary 5.2(f) Notice of Redemption 7.13(a) Notice 7.2(d)(iii) Notice Period 7.2(d)(iii) Original Date 7.4(b) Outside Date 9.2(a) Parent Preamble Parent Approvals 6.4(a) Parent Option 4.2(a)(iiDSU 4.2(f) Parent RSA 4.2(bOption 4.2(a) Parent RSU 4.2(c) Parent Tax Representation Letter 7.18(c) Parent SAR 4.2(e) Parties Preamble Permitted Confidentiality Agreement 7.2(b)(i) Potential Purchasers 7.6(d) Potential Sale Transaction 7.6(d) Privacy and Security Requirements Measures 5.18(k) Privacy-Related Contracts 5.11(a)(vi) Proxy Statement 7.3(a) Subsidiary Partnership 5.16(o) Stock Ownership Rep 6.8 Support Agreement Recitals Surviving Corporation 2.3 Tax Representation Letters 7.18(c) Third-Party Consents 7.8 Transaction Litigation 7.157.15 TRA Terminations 7.13(d) Vote-Down 9.2(b)

Terms Defined Elsewhere. As used The following terms are defined elsewhere in this Agreement, the following capitalized terms are defined in this Agreement as referenced in the following tableindicated below: Agreement Preamble Anti-Corruption Laws 5.5(dBoard Observer 5.3(b) Bylaws 3.2 Change of Recommendation 7.2(d)(i)(G) Charter 3.1 Closing 2.1 Closing Date 2.1 Company Preamble Company Approvals 5.4(aConfidential Information 5.2(a) Company Disclosure Letter Article V Company Personal Information 5.18(l) Company Recommendation 5.3(b) D&O Insurance 7.12(a) Delisting Period 7.18(a) Effective Time 2.2 Exchange Fund 4.3(a)(i) Excluded Share 4.1(b) Governmental Antitrust Entity 7.6(b)(ii) Interim Period 7.1(a) Lease 5.17(a) Legal Restraint 8.1(c) Material Contract 5.11(a)(xvi) Material Payor 5.12(a) Material Vendor 5.12(b) Merger Recitals Merger Consideration Corporate Opportunity Party 5.7 Demand 4.1(a) Merger Sub Preamble Demand Registration 4.1(a) Drag Notice 3.7(b) Drag-Along Sale 3.7(a) Dragged Shareholders 3.7(a) Dragging Shareholders 3.7(a) Excess Shares 2.1(c) Executive Transfer 3.2(c) Family Member 3.2(b) Form S-3 Registration Statement 4.3(b) Form S-3 Shelf Registration Statement 4.3(b) Fully Participating Shareholder 2.1(c) Initial Exercise Period 3.5(b) Initial Purchaser 2.1(g) Initiating Shelf Holder 4.4(a) IPO Holdback Period Appendix Legend 6.1 Marketed Underwritten Shelf Take-Down 4.4(b) New Issuance 2.1(a) New Issuance Notice 2.1(a) Non-Wholly Owned Subsidiary 5.2(fElecting Shares 3.6(d) Non-Marketed Underwritten Shelf Take-Down 4.4(c) Non-Marketed Underwritten Shelf Take-Down Notice 4.4(d) Notice 7.2(d)(iiiRecipient 4.4(d) Offer Notice Period 7.2(d)(iii3.5(a) Original Date 7.4(bOffer Price 3.5(a) Outside Date 9.2(aOffered Securities 2.1(a) Parent Preamble Parent Approvals 6.4(a) Parent Option 4.2(a)(ii) Parent RSA 4.2(b) Parties Preamble Permitted Confidentiality Agreement 7.2(b)(i) Potential Purchasers 7.6(d) Potential Offered Tag-Along Sale Transaction 7.6(d) Privacy and Security Requirements 5.18(k) Proxy Statement 7.3(a) Subsidiary Partnership 5.16(o) Surviving Corporation 2.3 Third-Party Consents 7.8 Transaction Litigation 7.15Shares 3.6(b)

Terms Defined Elsewhere. As The following is a list of additional terms used in this Agreement, Agreement and a reference to the following capitalized terms are defined Section hereof in this Agreement as referenced in the following tablewhich such term is defined: AAA Section 9.3(b) Adjustment Event Section 2.6 Aggregate Company Consideration Section 2.2(b) Aggregate N.Z. Consideration Section 2.1(b) Aggregate U.S. Consideration Section 2.1(a) Agreement Preamble Anti-Corruption Arbitrator Section 9.3(b) Australian Business Number Section 4.12(a) Australian Company Preamble Australian Indemnification Obligations Section 9.2(a)(i) Blue Sky Laws 5.5(dSection 4.17 Cash Consideration Section 2.4(b) Bylaws 3.2 Change of Recommendation 7.2(d)(i)(GCash Percentage Section 2.4(a) Charter CERCLA Section 4.13 Claim Notice Section 9.3(a) Closing Section 3.1 Closing 2.1 Closing Date 2.1 Section 3.1 Company Cap Section 9.5(b) Company Marks Section 4.20(b) Company Patents Section 4.20(c) Company Percentage Interest Section 2.2(b) Company Registered Copyrights Section 4.20(d) Company Registered IP Section 4.20(g) Company Shareholders Recitals Company Shares Recitals Company Software Section 4.20(l) Copyrights Section 4.20(a) Damages Section 9.2(a) Disposition Section 6.9 Dispute Notice Section 9.3(b) Double Taxation Agreement Section 4.12(a) Effective Period Section 6.2(d) Employee Loans Section 4.8(a) Escrow Account Section 2.5 Escrow Agent Section 2.5 Escrow Amount Section 2.5 Escrow Shares Section 2.5 Escrow Value Section 9.6 Foreign Status Certificate Section 3.2(n) GST Section 4.12(a) Hazardous Materials Section 4.13 Holder Section 6.2(f)(iii) Inbound License Agreements Section 4.20(i) Indemnified Party Section 9.3(a) Indemnitor Section 9.3(a) Intellectual Property Section 4.20(a) Lock-up Section 6.9 Lock-up Period Section 6.9 Marks Section 4.20(a) Mask Works Section 4.20(a) Material Contracts Section 4.8(a) Net Cash Deficit Section 2.7(b) Net Cash Estimate Section 2.7(a) N.Z. Company Preamble Company Approvals 5.4(aN.Z. Purchase Price Section 2.1(d) Company Disclosure Letter Article V Company Personal Information 5.18(lN.Z. Shareholders Recitals N.Z. Shares Recitals Net Cash Estimate Section 2.7(a) Company Recommendation 5.3(b) D&O Insurance 7.12(a) Delisting Period 7.18(a) Effective Time 2.2 Exchange Fund 4.3(a)(i) Excluded Share 4.1(b) Governmental Antitrust Entity 7.6(b)(ii) Interim Period 7.1(a) Lease 5.17(a) Legal Restraint 8.1(c) Material Contract 5.11(a)(xvi) Material Payor 5.12(a) Material Vendor 5.12(b) Merger Recitals Merger Consideration 4.1(a) Merger Sub Preamble Non-Wholly Owned Subsidiary 5.2(f) Notice 7.2(d)(iii) Notice Period 7.2(d)(iii) Original Date 7.4(b) OSR Section 6.14 Outside Date 9.2(aSection 8.1(b) Parent Preamble Parent Approvals 6.4(aSEC Documents Section 5.5 Patents Section 4.20(a) Parent Option 4.2(a)(ii) Parent RSA 4.2(b) Parties Preamble Permitted Confidentiality Agreement 7.2(b)(i) Potential Purchasers 7.6(d) Potential Sale Transaction 7.6(dPersonal Element Section 4.20(p) Privacy and Security Requirements 5.18(kPolicies Section 4.20(p) Proxy Proceeding Section 4.18 Purchaser Preamble Purchaser Indemnified Parties Section 9.2(a) Real Property Section 4.5(c) Registration Indemnified Party Section 6.2(g)(iii) Registration Indemnifying Party Section 6.2(g)(iii) Registration Statement 7.3(aSection 6.2(a) Subsidiary Partnership 5.16(oShare Consideration Section 2.4(b) Surviving Corporation Share Percentage Section 2.4(a) Shareholder Indemnified Parties Section 9.2(b) Shares Section 2.3 Third-Party Consents 7.8 Software Section 4.20(l) Tax Section 4.12(a) Tax Return Section 4.12(a) Taxable Section 4.12(a) Taxes Section 4.12(a) Threshold Amount Section 9.5(a) Trade Secrets Section 4.20(a) Transaction Litigation 7.15Fees Section 10.12 U.S. Company Preamble U.S. Purchase Price Section 2.1(b) U.S. Shareholder Recitals U.S. Shares Recitals Unique Identifying Number Section 4.20(p) Unstamped Transfers Section 6.14 User Data Section 4.20(p) Violation Section 6.2(g)(i)

Terms Defined Elsewhere. As used in this Agreement, Each of the following capitalized terms are is defined in this the Section set forth opposite such term: 401(k) Termination Date 8.03(c) Acceptable Confidentiality Agreement as referenced in the following table: 6.02(b) Agreement Preamble Anti-Corruption Laws 5.5(dAncillary Scheme Documentation Section 3.01(a)(ii) Bylaws 3.2 Apple Preamble Apple Adverse Recommendation Change of 6.02(a) Apple Approval Time 6.02(b) Apple Board Recitals Apple Board Recommendation 7.2(d)(i)(G4.02(b) Charter 3.1 Apple Organizational Documents 4.01 Apple Payment Fund 2.01(b) Apple Permits 4.12 Apple Registered IP 4.19(a) Apple Regulatory Agency 4.14(a) Apple Regulatory Permits 4.14(a) Apple SEC Documents 4.07(a) Bankruptcy and Equity Exceptions 4.02(a) Capitalization Date 4.05(a) Cash Consideration 2.01(a) Closing 2.1 1.02 Closing Date 2.1 Company Preamble Company Approvals 5.4(a1.02 Continuing Employees 8.03(a) Company Disclosure Letter Article V Company Personal Information 5.18(lCourt Documentation 3.01(a)(viii) Company Recommendation 5.3(bCourt Order 1.03 CVR 2.01(a) D&O Insurance 7.12(aCVR Agreement Recitals Depositary Custodian 2.01(b) Delisting Period 7.18(a) Effect Material Adverse Effect definition Effective Time 2.2 Exchange Fund 4.3(a)(i1.03 EMA Section 4.14(e) End Date 10.01(b)(i) Excluded Benefits Section 8.03(a) FDA 4.14(a) FDCA 4.14(a) Forms of Proxy 3.01(a)(ii) In-the-Money Unvested Apple Share 4.1(bOption 2.02(c) Governmental Antitrust Entity 7.6(b)(ii2.01(b) Interim Period 7.1(aIn-the-Money Vested Apple Share Option Section 2.02(c) Lease 5.17(aSection 2.01(d) Legal Restraint 8.1(cIndemnified Party 7.01(b) Labor Agreement 4.15(a)(iii) Leases 4.21 Material Contract 4.15(a) Material Contract 5.11(a)(xviSupplier 4.27 Maximum Amount 7.01(c) Material Payor 5.12(aNasdaq 4.03 New Plans 8.03(b) Material Vendor 5.12(bNo-Vote Termination Fee Section 10.03(a)(iii) Merger Recitals Merger Consideration 4.1(a) Merger Sub Preamble Non-Wholly Owned Subsidiary 5.2(fU.S. Plan 4.17(j) Notice 7.2(d)(iiiOld Plans 8.03(b) Notice Period 7.2(d)(iiiOrdinary Termination Fee 10.03(a)(ii) Original Date 7.4(b) Outside Date 9.2(a) Parent Preamble Parent Approvals 6.4(a) Parent Option 4.2(a)(ii) Parent RSA 4.2(bOther Required Filing 3.01(a)(iii) Parties Preamble Permitted Confidentiality Agreement 7.2(b)(iPaying Agent 2.01(b) Potential Purchasers 7.6(dPayoff Letter Section 8.08 Per ADS Cash Consideration 2.01(a) Potential Sale Per ADS CVR 2.01(a) Per ADS Transaction 7.6(dConsideration 2.01(a) Privacy and Security Requirements 5.18(kPHSA 4.14(a) Proxy Statement 7.3(a3.01(a)(i) Subsidiary Partnership 5.16(oProtected Data Section 4.20(c) Surviving Corporation 2.3 ThirdPurchaser Preamble Purchaser Board Recitals Purchaser Organizational Documents Section 5.04 Real Properties 4.21 Regulation S-Party Consents 7.8 K 4.07(g) Relevant Participant Section 2.02(i) Retention Award Section 8.03(h) Retention Pool Section 8.03(h) Rights Agent Recitals Scheme Document Annex 3.01(a)(i) Second Request 8.02(c) Senior Counsel 3.01(a)(x) Tail Coverage Section 7.01(c) Takeover Code Section 4.26 Transaction Recitals Transaction Consideration 2.01(a) Transaction Documentation Section 3.01(a)(iv) Transaction Litigation 7.156.03 Transfer Taxes 11.04 Transition Award Section 2.02(i) Transitional Cash Plan Section 2.02(i) Unvested Apple PSU Section 2.02(g) Unvested Apple RSU Section 2.02(f) Unvested Awards Section 2.02(i) Unvested Cash Consideration Section 2.02(j) Unvested CVR Consideration Section 2.02(j) IN THE HIGH COURT OF JUSTICE CR - [2023] - [●]